Aldena Therapeutics selects PCI Pharma Services to manufacture and distribute innovative investigational treatment for dermatological diseases
Analytical method development in a high potent facility
Integrated, scalable solutions that accelerate drug products from development to commercialisation and beyond: speedsolutions
Containment in a high potent manufacturing facility
PCI's automated sterile fill-finish machines now operational
Robotic aseptic processing
CDMOs deliver increased performance for pharma clients with agility and innovation
PCI expands biologics with Midwest “centre of excellence”
Outsourcing your highly potent oncology drug product
Addressing rare disease drug product manufacturing challenges
PCI Pharma Services announces multimillion dollar expansion to UK manufacturing facility
Humanigen and PCI partner to prepare for commercialisation in the UK
PCI Pharma Services announces major manufacturing expansion with $100 million investment in New England
PCI announces clinical centre of excellence in Boston
Biologics and specialty medicines: planning your packaging from clinic to launch (part I)
PCI Pharma expands cold chain supply storage in Berlin
